Pivotal bioVenture Partners Investment Advisor as of June 30, 2025
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 12 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Oculis Holding Ordinary Shares (OCS) | 27.7 | $45M | 2.3M | 19.41 | |
| Vaxcyte (PCVX) | 26.3 | $42M | 1.3M | 32.51 | |
| Arcutis Biotherapeutics (ARQT) | 18.4 | $30M | 2.1M | 14.02 | |
| Inozyme Pharma (INZY) | 11.1 | $18M | 4.5M | 4.00 | |
| Zenas Biopharma (ZBIO) | 4.7 | $7.5M | 779k | 9.69 | |
| Trevi Therapeutics (TRVI) | 3.9 | $6.3M | 1.1M | 5.47 | |
| Vigil Neuroscience (VIGL) | 2.8 | $4.5M | 561k | 7.95 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 1.9 | $3.0M | 596k | 5.06 | |
| Bioage Labs (BIOA) | 1.7 | $2.7M | 653k | 4.13 | |
| Io Biotech (IOBT) | 0.7 | $1.2M | 864k | 1.39 | |
| Rallybio Corp (RLYB) | 0.5 | $813k | 2.4M | 0.34 | |
| Bolt Biotherapeutics Com New (BOLT) | 0.3 | $546k | 95k | 5.77 |
